Learn about Multiple Myeloma (cancer in the blood)

The following information is being shared with you on behalf of West Glen and The Mount Sinai Medical Center.*

mount sinai logoMultiple Myeloma is a cancer in the blood that affects the lives of many throughout the United States. The Mount Sinai Medical Center would like to tell you about “Leadership To Cure,” aimed at providing the public with knowledge of the disease. They would also like to share an inspirational story of hope about a remarkable mother and her twin miracles, Dahlia and Sonya.

As with any illness, optimism can often dwindle over time, so it’s important to always share stories of hope with one another to show our support! Meet Dina Feivelson, diagnosed with Multiple Myeloma stage 3 in 2002 at the age of 32. When Dina was first diagnosed, no one thought she would see 40. Well, as you will learn, she proved statistics wrong with the help of her doctor and a miracle happened, as 8 years later Dina turned 40, and that same year she also gave birth to her girls.  It’s a different life than anyone expected she’d be able to have and now Dina proudly shares her story with other mothers, as she is a true inspiration. Read Dina’s story here.

Dina’s light throughout this battle has been Dr. Sundar Jagannath, or Dr. “Jag” as she calls him, professor of medicine at Mount Sinai School of Medicine and the director of the Multiple Myeloma program. He is leading the way to build projects at Mount Sinai that bridge basic science and clinical practices for the benefit of advancing care in blood cancer patients everywhere.  The good news is that the current standard of care for Multiple Myeloma has dramatically improved over the past 10 years, especially with the approval of new drugs.

We encourage you to learn more and to share this story with others!

Video and resources for this program can be found at leadershiptocure.com.


*No compensation was received in exchange for the posting of this material.

join the mommy perks community


Click Here to Leave a Comment Below

Leave a Reply: